Results 181 to 190 of about 35,928 (280)

Normal Immune Function in a Newborn With Early Identification of a <i>SAMD9</i> Mutation Presenting With Growth Restriction, Thrombocytopenia, and Primary Adrenal Insufficiency. [PDF]

Clin Case Rep
Gao KM, Huang QYJ, Huang P, Muzaffar A, Beheshti R, Wood R, Dantzer J, Gutierrez MJ.   +7 more
europepmc   +1 more source

Long‐term results of palliative placement of very low‐axial force self‐expandable metallic stents for malignant colorectal obstruction

DEN Open, Volume 6, Issue 1, April 2026.
Abstract Objectives Stent placement is a standard option for palliative decompression in patients with malignant colorectal obstruction. Long‐term stent placement is associated with perforation, migration, and stent occlusion. Perforation is associated with life expectancy.
Rika Kyo, Takashi Sasaki, Shuntaro Yoshida, Hiroyuki Isayama, Tomonori Yamada, Toshiyuki Enomoto, Yorinobu Sumida, Toshio Kuwai, Masafumi Tomita, Takeaki Matsuzawa, Rintaro Moroi, Toshiyasu Shiratori, Yoshihisa Saida   +12 more
wiley   +1 more source

Identifying Knowledge Gaps in Individuals With Primary Adrenal Insufficiency: A Critical Step in Preventing Adrenal Crisis. [PDF]

Clin Endocrinol (Oxf)
Ross IL, Llahana S, Anderson MM, Demeke B, Minnie EM, Wass JAH, Henry M.   +6 more
europepmc   +1 more source

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

International Journal of Cancer, Volume 158, Issue 6, Page 1654-1665, 15 March 2026.
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke, Karl Mayrhofer, Johanna Krauter, Johannes Franke, Dominic Vais, Maximillian Pallauf, David Kiesl, Ferdinand Luger, Jacob Pfuner, Angelika Terbuch, Thomas Bauernhofer, Jasmin Spielgelberg, Andreas Banner, Stefan Aufderklamm, Clemens Wiesinger, Susanne Schnabel, Simon Peter Gampenrieder, Josef Mühlmann, Sonia Vallet, Sabine Weibrecht, Franz Stoiber, Haleh Andalibi, Harun Fajkovic, Hossein Taghizadeh, Jan Miechowiecki, Roman Taedcke, Daniel Heintel, Shahrokh F. Shariat, Martin Pichler, Wolfgang Hilbe, Renate Pichler   +30 more
wiley   +1 more source

Mild Primary Adrenal Insufficiency During Treatment With Lenvatinib and Pembrolizumab: A Report of 3 Patients. [PDF]

JCEM Case Rep
Yamabayashi E, Obata Y, Kozawa J, Nishizawa H, Shimomura I.   +4 more
europepmc   +1 more source

Primary Adrenal Insufficiency in Autoimmune Polyglandular Syndrome Type 1 - A Case Report and Literature Review

Hafiza Qadeer, Reshma Samkutty, Caitlyn Moss   +2 more
openalex   +2 more sources

KRAS‐G12C: The neglected biomarker to detect patients with MUTYH‐associated polyposis

International Journal of Cancer, Volume 158, Issue 6, Page 1588-1598, 15 March 2026.
What's new? MUTYH‐associated polyposis is an underdiagnosed recessive syndrome that predisposes individual to colorectal cancer and frequently displays KRAS‐G12C mutations. By analyzing a large cohort of colorectal cancer patients routinely tested for KRAS, the authors assessed whether KRAS‐G12C detection could serve as a pre‐screening tool for the ...
Ana Beatriz Deleame Medeiros, Gabriel Oliveira dos Santos, José Claudio Casali‐da‐Rocha, Samuel Aguiar Junior, Virgilio Souza e Silva, Gustavo Nóriz Berardinelli, Augusto Perazzolo Antoniazzi, Rui Manuel Reis, Dirce Maria Carraro, Giovana Tardin Torrezan   +9 more
wiley   +1 more source

Laparoscopic sleeve gastrectomy in a patient with primary adrenal insufficiency: a case report. [PDF]

J Surg Case Rep
Nemri AA, Alshehri K, Alshahrani A, Abdulhaq M, Alageel AH.   +4 more
europepmc   +1 more source

Lateral Deviation of the Tongue in an Otherwise Asymptomatic Patient

Oral Diseases, EarlyView.
Giulia Ghidini, Alessandro Olivari, Sebastiano Buti, Paolo Vescovi, Maddalena Manfredi   +4 more
wiley   +1 more source

Cancer Comorbidities: Clinical Impacts, Mechanistic Insights, and Management Strategies

MedComm – Oncology, Volume 5, Issue 1, March 2026.
This review focuses on cancer comorbidities, examining their clinical impacts and mechanistic insights. It further examines key management challenges, including evidence gaps, the lack of precise assessment tools, limited management frameworks, and underdeveloped multidisciplinary collaborations.
Taoxing Peng, Siyi Chen, Xin He, Yuxin Yang, Yuexiang Ren, Yuxuan Sun, Fuli Shi, Yangfeng Lv, Xiangqiong Wen, Yujian Wen, Peng Yu, Weizhu Liu, Qiongfeng Chen, Xianhe Yang, Shan Xu, Jianming Li   +15 more
wiley   +1 more source